Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: Effect of MK-801 and CGP 39551 on neurotransmitter and glial markers
- 31 May 1992
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 31 (5) , 469-474
- https://doi.org/10.1016/0028-3908(92)90085-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Anticonvulsant Activity of Two Orally Active Competitive N‐Methyl‐D‐Aspartate Antagonists, CGP 37849 and CGP 39551, Against Sound‐Induced Seizures in DBA/2 Mice and Photically Induced Myoclonus in Papio papioEpilepsia, 1991
- Ketamine, Phencyclidine, and MK‐801 Protect Against Kainic Acid‐Induced Seizure‐Related Brain DamageEpilepsia, 1990
- Quantitative assessment of neuroprotection against NMDA-induced brain injuryExperimental Neurology, 1989
- Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonistEpilepsy Research, 1989
- Excitotoxity and the NMDA receptorTrends in Neurosciences, 1987
- Hypoglycemia-Induced Neuronal Damage Prevented by an N -Methyl-D-Aspartate AntagonistScience, 1985
- Regional development of glutamine synthetase activity in the rat brain and its association with the differentiation of astrocytesDevelopmental Brain Research, 1983
- The behavioural effects of systemically administered kainic acid: A pharmacological analysisLife Sciences, 1981
- Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlatesBrain Research, 1981
- LOCALIZATION OF GABAERGIC, CHOLINERGIC AND AMINERGIC STRUCTURES IN THE MESOLIMBIC SYSTEMJournal of Neurochemistry, 1977